Edition One brought 400 applications, 110 builders, and zero drop-outs to ETH Zürich. Edition Two is being built now.
> 110 builders. ETH Zürich. May 8–10, 2026. Captured live.
Received before the event even took place.
We planned for 80. The bar held.
Zero. Across two full days.
France, Germany, Czechia, Greece, Italy, Ireland, UK, Switzerland.
From kick-off to the jury room.
By design, not by accident.
Edition One ran for thirty-six hours straight. These are the rooms teams walked into.
Teams shipped against the working edge of clinical genomics — pipelines that have to be right, fast, and defensible the same week they land in front of a clinician.
Pipeline acceleration for early-stage research. Simulation, screening, and the unglamorous middle layer that decides whether a candidate moves or dies in the lab.
Decision-support, agents, and clinical copilots that have to hold up when a real shift starts. Not demoware. Software a nurse, a researcher, or a clinician would actually pick up twice.
Edition One was judged and mentored by founders, scientists, and operators from Roche, SOPHiA GENETICS, LEVY Health, and beyond.
Co-Founder & CPO
LEVY Health
CTO
SOPHiA GENETICS
Founder
kourageX
Product Manager & Lecturer
Innovation & Design Thinking
CEO
Sustainable Finance
Entrepreneur & Advisor
Health Innovation
Head BioMed Entrepreneurship Programs
Life Science Startup Supporter
Co-Founder & CPO
LEVY Health
CTO
SOPHiA GENETICS
Founder
kourageX
Product Manager & Lecturer
Innovation & Design Thinking
CEO
Sustainable Finance
Entrepreneur & Advisor
Health Innovation
Head BioMed Entrepreneurship Programs
Life Science Startup Supporter
Expert
Cell Biology & Protein Design
Founder · Investor · Researcher
Digital Health & Health Tech
Senior Principal Scientist
Roche
Founder & CEO
Tech & Innovation
Research Scientist
Mentor
Health Tech
Expert
Cell Biology & Protein Design
Founder · Investor · Researcher
Digital Health & Health Tech
Senior Principal Scientist
Roche
Founder & CEO
Tech & Innovation
Research Scientist
Mentor
Health Tech
We work with sponsors, VCs, pharma innovation teams, foundations, and Fördergeber. Four ways the partnership pays back.
Direct access to a curated cohort of health-tech builders. Hire ahead of the market.
A jury seat or owned challenge track means your problem is the brief. Work is built around your priorities.
Brand presence across applicants, alumni, press, universities, and the hercode network.
Aligned with 2026 pharma and health-tech innovation budgets. Procurement lead time is built in.
Tell us what you're working on. We will come back with the tier sheet and a date.